Combination therapy tablets featuring SGLT2 inhibitor dapagliflozin alongside metformin for adult type 2 diabetes. Manufactured for export and domestic markets, sourced by procurement departments in multispecialty hospitals and independent pharmacies for administration under endocrinology and cardiology oversight.